| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 30.255 | 44.158 | 39.830 | 43.018 | 57.373 | 73.241 |
| Total Income - EUR | - | - | - | - | 30.255 | 47.260 | 39.832 | 43.020 | 57.374 | 73.242 |
| Total Expenses - EUR | - | - | - | - | 14.221 | 28.342 | 33.740 | 33.961 | 38.958 | 47.898 |
| Gross Profit/Loss - EUR | - | - | - | - | 16.034 | 18.918 | 6.091 | 9.059 | 18.416 | 25.344 |
| Net Profit/Loss - EUR | - | - | - | - | 15.733 | 18.601 | 5.812 | 8.637 | 17.883 | 23.410 |
| Employees | - | - | - | - | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Alfa Şi Omega Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 1.540 | 20.062 | 15.778 | 11.605 | 7.360 | 3.500 |
| Current Assets | - | - | - | - | 15.866 | 32.152 | 22.563 | 14.559 | 23.238 | 28.762 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 4.522 | 4.126 | 4.063 | 11.111 | 9.581 | 7.383 |
| Cash | - | - | - | - | 11.344 | 28.026 | 18.500 | 3.448 | 13.657 | 21.379 |
| Shareholders Funds | - | - | - | - | 15.775 | 22.748 | 16.933 | 8.685 | 17.931 | 23.956 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.657 | 29.564 | 21.497 | 17.561 | 12.756 | 8.655 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Alfa Şi Omega Med S.r.l.